Exploratory analysis of ribociclib plus letrozole in recurrent low-grade serous ovarian carcinoma: Impact of prior therapy, chemotherapy exposure, and age (GOG-3026).

Saved in:
Bibliographic Details
Title: Exploratory analysis of ribociclib plus letrozole in recurrent low-grade serous ovarian carcinoma: Impact of prior therapy, chemotherapy exposure, and age (GOG-3026).
Authors: Podder, Vivek1 (AUTHOR), Coleman, Robert2 (AUTHOR), Deng, Wei3 (AUTHOR), Weroha, John4 (AUTHOR), Chon, Hye Sook5 (AUTHOR), Vogel, Tilley Jenkins6 (AUTHOR), Backes, Floor7 (AUTHOR), Thomas, Eric8 (AUTHOR), Chen, Lee-may9 (AUTHOR), Tenney, Meaghan Elizabeth10 (AUTHOR), Westin, Shannon11 (AUTHOR), Markham, Merry12 (AUTHOR), Miller, David13 (AUTHOR), Edelson, Mitchell14 (AUTHOR), O'Malley, David7 (AUTHOR), Herzog, Thomas15 (AUTHOR), Gershenson, David16 (AUTHOR), Slomovitz, Brian1 (AUTHOR)
Source: Gynecologic Oncology. May2026:Supplement, Vol. 208, pS81-S82. 2p.
Database: Academic Search Ultimate
Description
ISSN:00908258
DOI:10.1016/j.ygyno.2026.01.131